Arbutus Biopharma's market cap is currently $651.85M. The company's EPS TTM is $-0.426; its P/E ratio is ―; Arbutus Biopharma is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 18.14M	$ 39.02M	$ 10.99M	$ 6.91M	$ 6.01M
Gross Profit	$ -55.56M	$ 37.59M	$ 9.23M	$ -40.57M	$ -51.59M
Operating Income	$ -78.10M	$ -65.46M	$ -73.52M	$ -57.81M	$ -144.07M
EBITDA	$ -70.99M	$ -61.86M	$ -71.64M	$ -57.81M	$ -147.32M
Net Income	$ -72.85M	$ -69.46M	$ -77.35M	$ -65.21M	$ -153.72M
Balance Sheet
Cash & Short-Term Investments	$ 126.00M	$ 146.91M	$ 155.32M	$ 123.27M	$ 90.83M
Total Assets	$ 144.40M	$ 195.42M	$ 204.49M	$ 137.08M	$ 105.53M
Total Debt	$ 8.72M	$ 2.19M	$ 2.61M	$ 2.98M	$ 3.36M
Net Debt	$ -17.56M	$ -28.59M	$ -106.67M	$ -49.27M	$ -28.44M
Total Liabilities	$ 38.38M	$ 58.57M	$ 35.05M	$ 35.11M	$ 32.79M
Stockholders' Equity	$ 106.02M	$ 136.85M	$ 169.44M	$ 101.97M	$ 72.74M
Cash Flow
Free Cash Flow	$ -86.94M	$ -35.87M	$ -68.34M	$ -51.67M	$ -71.59M
Operating Cash Flow	$ -85.94M	$ -35.36M	$ -67.53M	$ -51.44M	$ -71.01M
Investing Cash Flow	$ 50.77M	$ -74.94M	$ -12.68M	$ -14.91M	$ 28.34M
Financing Cash Flow	$ 30.65M	$ 31.81M	$ 137.24M	$ 86.75M	$ 37.46M

Currency in USD

Arbutus Biopharma Earnings and Revenue History

Income Statement >

Arbutus Biopharma Debt to Assets

Balance Sheet >

Arbutus Biopharma Cash Flow

Cash Flow >

Arbutus Biopharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing